Jon Congleton – Biography
Last update: March 24, 2026Executive profile
Jon was President and Chief Executive Officer at Impel Pharma, and Senior Vice President, Global Medicines Group at Teva Pharmaceuticals. Jon Congleton joined Mineralys Therapeutics in 2026.
Jon Congleton is currentlyChief Executive Officer at Mineralys Therapeutics - View - Mineralys Therapeutics org chart
Director at Avalyn Pharma - View - Avalyn Pharma org chart
Director at Immunic - View - Immunic org chart
Create your alert
to follow the career of Jon Congleton.
Education
Jon Congleton has a Bachelor of Science in Marketing from Kansas State University.
They have also studied at Kansas State University :
Find more alumni from Kansas State University
More about Jon Congleton
Do you need to know more about Jon Congleton? More results.
Participate
Social media
- Jon Congleton on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Jon Congleton
The colleagues of Jon Congleton
Company Colleagues
- At Mineralys Therapeutics, Jon Congleton has 27 colleagues including Daphne Karydas (Director), BT Slingsby (Director)…
- At Avalyn Pharma, Jon Congleton has 30 colleagues including Lyn Baranowski (CEO), Erin Lavelle (Director)…
- At Immunic, Jon Congleton has 31 colleagues including Erik Lundgren (CEO), Mike Bonney (Chairman of the Board)…
Industry Colleagues
- In the Biotechnology industry, Jon Congleton has 35,757 colleagues in 2,406 companies located in 42 countries. 16,893 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Jon Congleton.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Jon Congleton.
